Navigation Links
Children's HIV Drugs May Cause High Cholesterol

FRIDAY, Aug. 5 (HealthDay News) -- Children with HIV who receive antiretroviral treatments have persistently high cholesterol and other blood fat (lipid) levels, and would benefit from guidelines aimed at reducing their long-term heart risks, researchers say.

The findings are published in JAIDS: Journal of Acquired Immune Deficiency Syndromes.

"Formal guidelines are the first crucial step in minimizing cardiovascular disease complications and maximizing quality of life in this vulnerable population," the authors of an editorial said in a journal news release. The most effective strategy probably consists of a "lipid-friendly" drug regimen -- meaning medications that don't affect blood fats -- along with lifestyle changes, such as diet and exercise, they said.

The editorial accompanies two studies in the Aug. 15 issue that examined blood fats in children treated for HIV.

In one study, led by Denise L. Jacobson of Harvard School of Public Health, the researchers followed 240 HIV-infected children with high cholesterol for two years. During this time, the children had persistently high lipid levels. Cholesterol levels dropped to normal in only about one-third of the children.

Cholesterol levels were more likely to decline when changes were made to their antiretroviral treatment, the researchers found. In most cases, medication changes were related to the HIV, not lipid levels. Only 15 of the children were given drugs specifically to manage their cholesterol.

In a separate study, researchers at the Imperial College School of Medicine, London, compared the effect of different HIV drugs on 449 HIV-infected children's lipid levels. They found all of the drugs caused a surge in cholesterol. The class of HIV drugs known as protease inhibitors, in particular, triggered the biggest increase.

Within five years, 10 percent of children developed low-density lipoprotein ("bad") cholesterol levels above the 95th percentile. But based on those numbers, only three patients needed to take cholesterol medication.

Because HIV-infected children are likely to live well into adulthood, the researchers said treatment strategies need to be developed that will protect them against heart disease later in life.

"Clinical trials are required to develop and test intervention strategies to protect against cardiovascular disease in children born with HIV, growing into adult life," Dr. Margaret P. Rhoads of Imperial College and co-authors wrote in the news release.

More information

The U.S. Centers for Disease Control and Prevention provides statistics on HIV/AIDS among children.

-- Mary Elizabeth Dallas

SOURCE: JAIDS: Journal of Acquired Immune Deficiency Syndromes, news release, Aug. 3, 2011

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Researcher at Childrens Hospital LA discovers way to overcome radiation resistance in leukemia
2. Parents Want Electronic Access to Their Childrens Docs: Survey
3. Cholesterol-lowering drugs may help prevent recurrent strokes in younger people
4. Are Newer MS Drugs Worth Their High Price Tag?
5. Cancer drugs may help treatment of schizophrenia
6. New mouse model for testing cancer drugs
7. Drugs Can Bring HIV-Infected Africans Normal Life Spans
8. UNC receives NIH grant to develop and test new drugs to block HIV infection
9. Drugs May Prevent HIV Spread Among Heterosexuals
10. Generic, Brand-Name Heart Drugs Seem to Have Same Effect on Thyroid
11. The metabolic effects of antipsychotic drugs
Post Your Comments:
Related Image:
Children's HIV Drugs May Cause High Cholesterol
(Date:11/27/2015)... ... November 27, 2015 , ... The men and ... nonprofit healthcare organizations in the country. They have overseen financial turnarounds, shown commitment ... advance the healthcare industry as a whole through their advocacy and professional efforts. ...
(Date:11/27/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk ... Term Support) into its Q-Suite 5.10 product line. , Making the change to ... of Asterisk that will receive not only security fixes, but feature and bug ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, family ... tests directly from their electronic medical record (EMR) without the need for redundant ...
(Date:11/26/2015)... ... 2015 , ... Jobs in hospital medical laboratories and in the imaging field ... agency Aureus Medical Group . These fields, as well as travel ... for healthcare jobs through the company’s website, , The leading healthcare ...
(Date:11/26/2015)... , ... November 26, 2015 , ... ... set of retro-fused, self-animating trailer titles with ProTrailer: Vintage. This newly styled ProTrailer ... classically-influenced trailer titles work with any font, giving users limitless opportunities to stylize ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... 26, 2015 ... the "2016 Global Tumor Marker Testing ... and Sales Segment Forecasts, Innovative Technologies, Instrumentation ... to their offering. --> ... "2016 Global Tumor Marker Testing Market: ...
(Date:11/26/2015)... , November 26, 2015 ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced ... combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced ... has found that immunotherapy can be efficiently combined ...
(Date:11/26/2015)... 2015 3D bioprinting market is ... a new report by Grand View Research Inc. Rising prevalence ... demands kidney transplantation is expected to boost the market growth, ... organ transplantation. --> 3D bioprinting market is ... a new report by Grand View Research Inc. Rising prevalence ...
Breaking Medicine Technology: